You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES

HIGHLIGHTS

EVENTS

Kedrion Biopharma supports the 2020 Primary Immunodeficiency Week

The company stands alongside the global PI community

read more 

EVENTS

World Hemophilia Day: socially distant but still united with patients

Now more than ever, Kedrion is renewing its commitment to those who live with this rare disorder

read more 
  1. EVENTS - 31-03-2014

    Award in the US for efforts to support hemophilia patients communities

    Kedrion’s Vice-President of North American Commercial Operations is “Man of the Year” for the Hemophilia Association of New Jersey

    read more 
  2. EVENTS - 11-02-2014

    Conference in Colombia: Professor Mannucci on the future of hemophilia

    The event, open to industry experts, patients’ associations and the scientific community, took place in Medellín on February 12th, 2014

    read more 
  3. PLASMA & BIOTHERAPIES - 27-11-2013

    Distribution of the first recombinant Factor VIII from human cells

    Kedrion to be the distributor in Italy over the next ten years. The indication is the treatment of…

    read more 
  4. CORPORATE - 11-11-2013

    Kedrion and La Kelley Communication for a donation in Pakistan

    500,000 IU of Factor IX shipped to the Pakistan Hemophilia Patients Welfare Society Rawalpindi.

    read more 

Pages

For more information please contact: pressoffice@kedrion.com